VEGFA and Sepsis: In this work, we found that VEGF-C156S posttreatment could improve the sepsis-inhibited pulmonary lymphatic function to reduce pulmonary inflammation and edema fluid by boosting inflammatory cells draining to lymph nodes, indicating that ameliorated pulmonary lymphatic function by VEGF-C156S posttreatment could promote inflammation resolution.